NCT02277548View on ClinicalTrials.gov

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions

Oropharyngeal CancerSquamous Cell Carcinoma to the Head and Neck

Interventions

DRUG

Lyrica 300 mg

Lyrica 300 mg per day

DRUG

Placebo

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02277548 - A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck. | Biotech Hunter | Biotech Hunter